Abstract Background Neuromodulation therapy has emerged as a potential brain cytoprotective strategy in the hyperacute phase of ischemic stroke (IS). This systematic review aimed to evaluate the cytoprotective effects of neuromodulation in animal models of IS. Methods A systematic search of the MEDLINE, Embase, and LIL...
I. Salles, M. Pellegrino, Jéssica Borges Kroth et al.· Neuroprotection· 0 citations
BackgroundCovert brain infarction (CBI) is a frequent incidental neuroradiological finding increasingly recognized as clinically relevant due to its association with stroke, cognitive decline, and other adverse outcomes. However, substantial uncertainty remains regarding its optimal assessment and management, and exist...
B. K. Vitturi, Terence J. Quinn, G. Thomalla et al.· International Journal of Str...· 0 citations
Abstract Background In high cardiovascular risk populations without prior stroke, intensive blood pressure (BP) lowering confers greater reductions in cardiovascular events than standard targets. However, optimal BP targets in patients with ischaemic stroke (IS) or TIA remain uncertain. The primary objective of the OPT...
G. Silva, M. J. Machline-Carrion, K. Santo et al.· European Stroke Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.